CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

E P Radiological Svc

E P Radiological Svc is a Canoga Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Profil Institute for Clinical Research

Profil Institute for Clinical Research is a Chula Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

James Graham Brown Foundation

James Graham Brown Foundation is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Audiotech Healthcare Corporation

Audiotech Healthcare Corporation is a Salmon Arm, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kerr Drug, Inc.

Kerr Drug recognizes that, for most of our customers, convenient access to products and services is a critical issue. That is why we go the extra mile to insure that our customers have the largest selection of things they need - everyday.